January 09, 2026 a 06:00 pm
RMD: Fundamental Ratio Analysis - ResMed Inc.
ResMed Inc., a prominent player in the healthcare markets, is recognized for its innovative solutions in sleep and respiratory care. With a global presence in over 140 countries, the company consistently shows robust financial health. The stock represents a compelling opportunity for investors interested in the medical technology sector.
Fundamental Rating (H2)
The fundamental metrics for ResMed Inc. reflect a solid performance in key areas, especially in financial health and operational efficiency.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 3 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
The historical ratings provide insights into the stock's performance improvement over time.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-01-09 | 4 | 4 | 5 | 5 | 3 | 2 | 1 |
| Previous | 0 | 4 | 5 | 5 | 3 | 2 | 1 |
Analyst Price Targets
Analyst projections indicate resilience in the stock's potential, with varied targets suggesting strategic evaluation opportunities.
| High | Low | Median | Consensus |
|---|---|---|---|
| $345 | $260 | $289.5 | $294 |
Analyst Sentiment
The sentiment reflects a predominantly positive outlook from analysts, primarily favoring 'Buy' recommendations.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 16 | |
| Hold | 13 | |
| Sell | 5 | |
| Strong Sell | 0 |
Conclusion
ResMed Inc. stands out as a leader in the healthcare industry, exhibiting reliable growth and robust financial metrics. While its price-to-earnings and price-to-book ratios suggest room for improvement, the company's innovations in respiratory care and software solutions hold promise. With a positive analyst consensus and stable cash flow management, ResMed presents opportunities but also necessitates careful consideration of market conditions. Investors should weigh growth potential against potential risks within the industry.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years